Page 1 | Search Results | Blood Advances | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim

Blood Adv (2020) 4 (18): 4474–4482.

https://doi.org/10.1182/bloodadvances.2020001627

Published: 2020

Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber

Blood Adv (2020) 4 (13): 3180–3190.

https://doi.org/10.1182/bloodadvances.2019001266

Published: 2020

Includes: Supplemental data

Journal Articles

Robust CD4 + T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin

Ioannis Politikos, Jessica A. Lavery, Patrick Hilden, Christina Cho, Taylor Borrill, Molly A. Maloy, Sergio A. Giralt, Marcel R. M. van den Brink, Miguel-Angel Perales, Juliet N. Barker

Blood Adv (2020) 4 (1): 191–202.

https://doi.org/10.1182/bloodadvances.2019000836

Published: 2020

Includes: Supplemental data

Journal Articles

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

J. B. Langenhorst, C. van Kesteren, E. M. van Maarseveen, T. P. C. Dorlo, S. Nierkens, C. A. Lindemans, M. A. de Witte, A. van Rhenen, R. Raijmakers, M. Bierings, J. Kuball, A. D. R. Huitema, J. J. Boelens

Blood Adv (2019) 3 (14): 2179–2187.

https://doi.org/10.1182/bloodadvances.2018029421

Published: 2019

Journal Articles

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Riitta Niittyvuopio, Johan Maertens, Xavier Poiré, Jan Cornelissen, Péter Reményi, Jean Henri Bourhis, Yves Beguin, Ram Malladi, Tessa Kerre, Wilfried Schroyens, Bipin N. Savani, Mohamad Mohty

Blood Adv (2019) 3 (13): 1950–1960.

https://doi.org/10.1182/bloodadvances.2019000030

Published: 2019

Includes: Supplemental data

Journal Articles

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia

Rohtesh S. Mehta, Shernan G. Holtan, Tao Wang, Michael T. Hemmer, Stephen R. Spellman, Mukta Arora, Daniel R. Couriel, Amin M. Alousi, Joseph Pidala, Hisham Abdel-Azim, Ibrahim Ahmed, Mahmoud Aljurf, Medhat Askar, Jeffery J. Auletta, Vijaya Bhatt, Christopher Bredeson, Saurabh Chhabra, Shahinaz Gadalla, James Gajewski, Robert Peter Gale, Usama Gergis, Peiman Hematti, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Carrie Kitko, Pooja Khandelwal, Margaret L. MacMillan, Navneet Majhail, David I. Marks, Parinda Mehta, Taiga Nishihori, Richard F. Olsson, Attaphol Pawarode, Miguel Angel Diaz, Tim Prestidge, Muna Qayed, Hemalatha Rangarajan, Olle Ringden, Ayman Saad, Bipin N. Savani, Sachiko Seo, Ami Shah, Niketa Shah, Kirk R. Schultz, Melhem Solh, Thomas Spitzer, Jeffrey Szer, Takanori Teshima, Leo F. Verdonck, Kirsten M. Williams, Baldeep Wirk, John Wagner, Jean A. Yared, Daniel J. Weisdorf

Blood Adv (2019) 3 (9): 1441–1449.

https://doi.org/10.1182/bloodadvances.2018030171

Published: 2019

Includes: Supplemental data

Journal Articles

Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin

Rosy Dabas, Kareem Jamani, Shahbal B. Kangarloo, Poonam Dharmani-Khan, Tyler S. Williamson, Samar Ousia, Caylib Durand, Don Morris, Douglas Mahoney, Lynn Savoie, Ahsan Chaudhry, Victor H. Jimenez-Zepeda, Faisal M. Khan, Andrew Daly, Jan Storek

Blood Adv (2019) 3 (9): 1394–1405.

https://doi.org/10.1182/bloodadvances.2018030247

Published: 2019

Includes: Supplemental data

Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant

Blood Adv (2019) 3 (2): 184–186.

https://doi.org/10.1182/bloodadvances.2018028282

Published: 2019

Journal Articles

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity

Mary Eapen, Ruta Brazauskas, Michael Hemmer, Waleska S. Perez, Patricia Steinert, Mary M. Horowitz, H. Joachim Deeg

Blood Adv (2018) 2 (16): 2095–2103.

https://doi.org/10.1182/bloodadvances.2018021980

Published: 2018

Journal Articles

Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation

Coco de Koning, Julie-Anne Gabelich, Jurgen Langenhorst, Rick Admiraal, Jurgen Kuball, Jaap Jan Boelens, Stefan Nierkens

Blood Adv (2018) 2 (5): 565–574.

https://doi.org/10.1182/bloodadvances.2017015487

Published: 2018

Includes: Supplemental data

Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani

Blood Adv (2017) 1 (17): 1347–1357.

https://doi.org/10.1182/bloodadvances.2017007716

Published: 2017

Includes: Supplemental data

Journal Articles

Alternative donor hematopoietic stem cell transplantation for sickle cell disease

Andrew L. Gilman, Michael J. Eckrich, Stacy Epstein, Carrie Barnhart, Mark Cannon, Tracy Fukes, Michelle Hyland, Krishna Shah, Darci Grochowski, Elizabeth Champion, Anastasia Ivanova

Blood Adv (2017) 1 (16): 1215–1223.

https://doi.org/10.1182/bloodadvances.2017005462

Published: 2017

Journal Articles

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Blood Adv (2017) 1 (13): 792–801.

https://doi.org/10.1182/bloodadvances.2016004119

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Robust CD4 + T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia

Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity

Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Alternative donor hematopoietic stem cell transplantation for sickle cell disease

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only